Leerink Upgrades Halozyme Therapeutics (HALO) to Outperform

August 7, 2026 7:02 AM

Leerink analyst David Risinger upgraded Halozyme Therapeutics (NASDAQ: HALO) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found